Four Tests, One Result

We offer four state-of-the-art tests: Molecular Identification, Molecular Antibiotic Gene Resistance, Antibiotic Sensitivity Testing, iQ Ab Guide

Industry Leading Testing

iQ Genetix Testing Capabilities


Molecular UTI With Antibiotic Gene Resistance And Antibiotic Sensitivity Combined With the iQ Genetix Intelligent Antibiotic Reference Guide

Respiratory Pathogen Panel

Rapid identification of respiratory pathogens and Coronavirus utilizing Quantitative Real-Time PCR Technology.


Molecular STI With Antibiotic Gene Resistance And Antibiotic Sensitivity With the iQ Genetix Intelligent Antibiotic Reference Guide

Gastrointestinal Pathogen Panel

Real-time PCR analyzes your patient's sample, identifies bacterial, viral, and parasitic pathogens & detects antibiotic drug resistant genes.


A sensitive molecular test that targets the detection of the SARS-CoV-2 genes and provide info as to which patients are infected.

Wound Pathogen Panel

Rapid pathogen identification using RT-PCR for wound management to detect polymicrobial organisms and antibiotic resistance.

Our Testing

Molecular UTI Panel

Urinary tract infections are among the most common types of illnesses among all ages. Each year, around 150 million people are affected by symptomatic or asymptomatic urinary tract infections, which could present serious health issues.

Molecular uti

What Seperates Our Tests

iQ Genetix

Interactive Antibiotic Guide for Molecular UTI Panel

We discover, develop, and market a transformative molecular diagnostic test that addresses pressing clinical needs across multiple medical specialties. Using state-of-the-art analytical equipment, automated specimen processing and advanced reporting applications.

Young female scientist working with microscope in laboratory
Intellegient Diagnostic Solutions

Introducing intelligent diagnostic solutions for antibiotic stewardship in partnership with the Sanford Guide. Antibiotic Stewardship involves making responsible decisions on when and how to prescribe antibiotic therapy.

Accurate Results

The CDC has stated that at least 30% of antibiotics prescribed in the US are either unnecessary or inappropriate. The other 70% is still in need of further customization in choosing the appropriate dosing due to the variability in metabolization and drug absorption.

Antibiotic Guide​

Integrated into an Antibiotic Stewardship program is the perfect solution in helping clinicians quickly decide:

Viral vs. Bacterial Etiology
Pathogen Load Testing
Antibiotic Resistance
Appropriate Antibiotic Guidance

An intelligent molecular based diagnostic solution that is routinely updated with the latest molecular and antibiotic information. This is a unique, data-driven approach that combines precise, molecular pathogen and resistance gene detection with sensitivity and susceptibility data (Sanford Guide®).

Supports clinicians in providing a more targeted and customized treatment plan through pharmacy guidance for their patients within 24 hours of the patient sample arriving at our lab. This guidance may consider the patient’s age, comorbidities, allergies, concomitant medications, regional susceptibility patterns in addition to the test results.

Our Testing

Molecular STI Panel

Sexually transmitted infections are diseases caused by microorganisms and viral infections that spread through sexual contact. When diagnosed in the early stages, many STIs can be easily treated and cured. STIs that remain undiagnosed or untreated can have serious health consequences. Individuals who are asymptotic are still at risk of long-term complications and can still spread the infection. For these reasons, it is important every sexually active individual be screened for STIs.

Chlamydia trachomatis and Neisseria gonorrhea are the two most common sexually transmitted infections. Currently, testing relies on culture, which takes at least 48 hours.

Current STI testing relies on lab culture to identify infections and any drug resistance. This takes at least 48 hours. In the meantime, the patient is prescribed a first-line antibiotic treatment. Pathogens resistant to these antibiotics can result in an ineffective first treatment.

Untreated or inappropriately treated STIs can lead to a range of secondary complications including pelvic inflammatory disease, infertility, complications in pregnancy, reproductive system cancers,
the enhanced transmission of HIV, and epididymitis. The emergence of drug-resistant strains of STI such as gonorrhea is also causing considerable global concern.

Doctor desk with documents and stethoscope


Up to 52% of women will be over-diagnosed with a UTI when visiting emergency departments with traditional UTI symptoms

Doctor explaining diagnosis to her female patient


Up to 50% of women diagnosed with a UTI will have a positive culture and 10-50% will have a STI

Stethoscope on keyboard


Over 37% of women will be underdiagnosed with an STI when visiting emergency departments with traditional UTI symptoms

Our Testing


PCR Tests

PCR tests are the “Gold Standard” for COVID-19 testing. They are sensitive molecular tests that target the detection of the SARS-CoV-2 genes and provide information as to which patients are currently infected.

The iQ Genetix Test

The iQ Genetix RT-PCR based SARS-CoV-2 test detects active COVID-19 infection with simple collection, reliable results, and same day turnaround once the sample is received by the lab.

Female scientist
Our Testing

Respiratory Pathogen Panel

The Respiratory Pathogen Panel quickly detects and differentiates viral and bacterial pathogens so effective treatment can begin sooner

The Respiratory Pathogen Panel utilizes quantitative Real-Time PCR to analyze your patient’s nasal sample and reports results in the same to 24 hours. The test precisely identifies 16 respiratory viruses and bacterial species, including Coronavirus from a single specimen.  Same day to 24-hour turnaround time, preventing delays in diagnosis and treatment

Our Testing

Gastrointestinal Pathogen Panel

Our Testing

Wound Pathogen Panel

Wound management can be complicated due to polymicrobial organisms and antibiotic resistance.

Multi-layered microbial communities, known as biofilms, surrounded by a self-produced protective extracellular slime further complicate a diagnosis.  More fastidious organisms may not be identified with standard culture, resulting in a delay in the appropriate treatment.

Additionally, the acquisition or emergence of resistance among bacteria that infect or colonize these wounds is a major health concern according to the CDC and the World Health Organization.

iQ Genetix Molecular Diagnostic Test

Leverages RT-PCR technology which precisely identifies pathogens enabling providers to prescribe early effective treatments, while preserving antibiotics effectiveness

Molecular Methods Are Advancing

It's now possible to use bacterial DNA from the wound site to identify the pathogens present. Our Wound Pathogen Panel rapidly establishes the microbiological profile of a sample and simultaneously reveals antibiotic resistance genes.